GoldenGolden
Z-Cube

Z-Cube

Z-Cube is an Italian venture capital firm and division of Zambon Pharmaceuticals, with a focus on strategic investments in translational medicine and drug delivery systems.

All edits

Edits on 23 Jan, 2020
Carla Faraguna
Carla Faraguna approved a suggestion from Golden's AI on 23 Jan, 2020
Edits made to:
Article (+5/-5 characters)
Article

Z-Cube is a Bresso, ItalyItaly based venture capital firm. A division of Zambon Pharmaceuticals, Zcube works to strategically invest in, develop and commercialize novel drug delivery systems in different therapeutic fields and in translational medicine.

Edits on 11 Nov, 2019
Aleksander Holm
Aleksander Holm approved a suggestion from Golden's AI on 11 Nov, 2019
Edits made to:
Article (+24/-24 characters)
Article

Z-Cube has made investments in SuppreMol, ProtAffin BiotechnologieProtAffin Biotechnologie and PharmEste. They exited their investment in SuppreMol.

Aleksander Holm
Aleksander Holm approved a suggestion from Golden's AI on 11 Nov, 2019
Edits made to:
Article (+6/-6 characters)
Article

Z-Cube is a BressoBresso, Italy based venture capital firm. A division of Zambon Pharmaceuticals, Zcube works to strategically invest in, develop and commercialize novel drug delivery systems in different therapeutic fields and in translational medicine.

Aleksander Holm
Aleksander Holm edited on 11 Nov, 2019
Edits made to:
Infobox (+6 properties)
Description (+172 characters)
Article (+1178 characters)
Categories (+1 topics)
Topic thumbnail

Z-Cube

Z-Cube is an Italian venture capital firm and division of Zambon Pharmaceuticals, with a focus on strategic investments in translational medicine and drug delivery systems.

Article

Z-Cube is a Bresso, Italy based venture capital firm. A division of Zambon Pharmaceuticals, Zcube works to strategically invest in, develop and commercialize novel drug delivery systems in different therapeutic fields and in translational medicine.

ZCare

Z-Cube includes their Zcare division which is devoted to use technology to deliver better value based health care results for patients and caregivers. They focus on chronic respiratory and CNS diseases to improve continuity of care, and work with doctors, nurses and healthcare professionals to increase information sharing, patient empowerment and closed loop servicing.

Open Accelerator

Another division of Z-Cube is the Open Accelerator. The Open Accelerator program is oriented towards identifying and accelerating new ideas or projects in the Italian business environment. The program lasts twelve weeks and have a chance to receive an initial investment of up to €100,000 and free office space. Open Accelerator looks for projects with strategic importance to Zambon's overall business.

Investment

Z-Cube has made investments in SuppreMol, ProtAffin Biotechnologie and PharmEste. They exited their investment in SuppreMol.

Infobox
Industry
Venture capital
Location
Parent organization
Categories
Edits on 11 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 11 Jul, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 9 Jul, 2019
Golden AI"Crunchbase 2013 Snapshot (C) 2013 https://data.crunchbase.com/docs/2013-snapshot#section-using-the-snapshot"
Golden AI edited on 9 Jul, 2019
Golden AI"Initial topic creation"
Golden AI created this topic on 9 Jul, 2019
Edits made to:
Topic thumbnail

 Z-Cube

Z-Cube is an Italian venture capital firm and division of Zambon Pharmaceuticals, with a focus on strategic investments in translational medicine and drug delivery systems.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.